BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23621794)

  • 1. Hand-foot syndrome caused by docetaxel with no recurrence after switch to paclitaxel, a different taxane.
    Corazza M; Minghetti S; Borghi A; Virgili A; Ballardini P
    Int J Dermatol; 2014 Mar; 53(3):e180-2. PubMed ID: 23621794
    [No Abstract]   [Full Text] [Related]  

  • 2. Paclitaxel-induced acral erythema.
    Richards KN; Ivan D; Rashid RM; Chon SY
    Arch Dermatol; 2012 Nov; 148(11):1333-4. PubMed ID: 23165853
    [No Abstract]   [Full Text] [Related]  

  • 3. [A trial for neoadjuvant chemotherapy of transarterial infusion of docetaxel in locally advanced breast cancer].
    Ohchi T; Kudo S; Doi K; Takahashi M; Sakamoto T; Ochiai T; Sakae T; Ishihara A; Kimura Y; Inoue K
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):143-5. PubMed ID: 10660749
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
    Akoglu G
    Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.
    Camacho LH; Kurzrock R; Cheung A; Barber DF; Gupta S; Madoff DC; Wallace MJ; Kim EE; Curley SA; Hortobagyi GN; Mavligit G
    Cancer; 2007 Jun; 109(11):2190-6. PubMed ID: 17464952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of weekly docetaxel and concurrent radiation for advanced breast cancer--case report].
    Kashiyama S; Ohnishi H; Kuriyama K; Komiyama T; Marino K; Araki T
    Gan To Kagaku Ryoho; 2005 May; 32(5):679-82. PubMed ID: 15918572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic erythema of chemotherapy.
    Repass TS; Wetter DA; Camilleri MJ
    Am J Hematol; 2012 Sep; 87(9):923. PubMed ID: 22072527
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer.
    Prevezas C; Matard B; Pinquier L; Reygagne P
    Br J Dermatol; 2009 Apr; 160(4):883-5. PubMed ID: 19222453
    [No Abstract]   [Full Text] [Related]  

  • 9. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
    Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
    Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 11. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
    Kara IO; Sahin B; Erkisi M
    Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.
    Radaideh SM; Sledge GW
    Breast Cancer Res Treat; 2008 Sep; 111(2):203-8. PubMed ID: 17990102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nail alterations secondary to pactitaxel [corrected] therapy.
    Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
    Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
    Morkas M; Fleming D; Hahl M
    J Clin Oncol; 2002 Feb; 20(3):867-9. PubMed ID: 11821473
    [No Abstract]   [Full Text] [Related]  

  • 17. Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer.
    Farhat MH; El-Saghir NS; Shamseddine AI
    Breast; 2009 Feb; 18(1):66-8. PubMed ID: 19013064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute abdomen in a chemotherapy treated breast cancer patient].
    Trébol J; Duarte M; Gil-López JM; García-Sancho L
    Cir Esp; 2009 Feb; 85(2):115-6. PubMed ID: 19231469
    [No Abstract]   [Full Text] [Related]  

  • 19. Taxane associated subacute cutaneous lupus erythematosus.
    Marchetti MA; Noland MM; Dillon PM; Greer KE
    Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology.
    Beuselinck B; Wildiers H; Wynendaele W; Dirix L; Kains JP; Paridaens R
    Crit Rev Oncol Hematol; 2010 Jul; 75(1):70-7. PubMed ID: 19651523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.